Stem Cell Treatment Market - Top Companies and Manufacturers

Companies Dominating the Stem Cell Treatment Landscape

Stemedica Cell Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Pluristem Therapeutics Inc.
Thermo Fisher Scientific
Becton, Dickinson and Company
Advanced Cell Technology Inc.
Cellular Engineering Technologies Inc.
CellGenix GmbH
PromoCell GmbH
Kite Pharma
Genea Biocells

Browse Key Market Insights with Data Illustration:

Stem Cell Treatment Market Size & Share, Growth Forecasts 2037

In the News

A new drug application (IND) has been approved by FDA for Stemedica Cell Technologies, Inc. in order to treat moderate-to-severe COVID-19 with intravenous administration of allogeneic mesenchymal stem cells (MSCs). This new application has shown to be effective in treating the symptoms of moderate-to-severe COVID-19, such as inflammation, fever, and difficulty breathing.
An official announcement from Pluristem Therapeutics Inc. announced that the company's subsidiary, Pluristem Ltd., has signed a non-binding Memorandum of Understanding (MOU) with the Abu Dhabi Stem Cells Center (ADSCC), a special healthcare center for cell therapy and regenerative medicine based in the United Arab Emirates.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of stem cell treatment is evaluated at USD 382.8 million.

The stem cell treatment market size was over USD 343.26 million in 2024 and is projected to exceed USD 1.97 billion by the end of 2037, growing at over 14.3% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of chronic and genetic diseases, along with the increasing awareness about the benefits of stem cell treatments will boost the market growth.

North America is poised to be the largest with a share of about 39% by 2037, propelled by increasing awareness about the potential of stem cell treatments, rising prevalence of chronic diseases such as diabetes, technological advancements in the field, and presence of favorable reimbursement policies in the region.

The major players in the market include Stemedica Cell Technologies, Inc., Pluristem Therapeutics Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Advanced Cell Technology Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell GmbH, Kite Pharma, Genea Biocells.

Stem Cell Treatment Market - Top Companies and Manufacturers

Companies Dominating the Stem Cell Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the stem cell treatment market?

What are the factors driving the stem cell treatment landscape?

Which region held the largest stem cell treatment industry share?

Who are the key players in the stem cell treatment sector?